Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination
The process of metastasis is complex 1 . In breast cancer, there are frequently long time intervals between cells leaving the primary tumour and growth of overt metastases 2 , 3 . Reasons for disease indolence and subsequent transition back to aggressive growth include interactions with myeloid and...
Gespeichert in:
Veröffentlicht in: | Nature cell biology 2020-03, Vol.22 (3), p.289-296 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The process of metastasis is complex
1
. In breast cancer, there are frequently long time intervals between cells leaving the primary tumour and growth of overt metastases
2
,
3
. Reasons for disease indolence and subsequent transition back to aggressive growth include interactions with myeloid and fibroblastic cells in the tumour microenvironment and ongoing immune surveillance
4
–
6
. However, the signals that cause actively growing cells to enter an indolent state, thereby enabling them to survive for extended periods of time, are not well understood. Here we reveal how the behaviour of indolent breast cancer cells in the lung is determined by their interactions with alveolar epithelial cells, in particular alveolar type 1 cells. This promotes the formation of fibronectin fibrils by indolent cells that drive integrin-dependent pro-survival signals. Combined in vivo RNA sequencing and drop-out screening identified secreted frizzled-related protein 2 (SFRP2) as a key mediator of this interaction.
Sfrp2
is induced in breast cancer cells by signals from lung epithelial cells and promotes fibronectin fibril formation and survival, whereas blockade of
Sfrp2
expression reduces the burden of indolent disease.
Montagner et al. show that lung epithelial cells induce
Sfrp2
expression and fibronectin fibril formation in disseminated breast cancer cells, thereby promoting their survival and latency in the lung. |
---|---|
ISSN: | 1465-7392 1476-4679 |
DOI: | 10.1038/s41556-020-0474-3 |